Kai Lucaßen

Investigation of Novel <i>pmrB</i> and <i>eptA</i> Mutations in Isogenic Acinetobacter baumannii Isolates Associated with Colistin Resistance and Increased Virulence <i>In Vivo</i>

Stefanie Gerson, Jonathan W. Betts, Kai Lucaßen et al. · Antimicrobial Agents and Chemotherapy · 2019 · 80 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Prevalence of RND efflux pump regulator variants associated with tigecycline resistance in carbapenem-resistant <i>Acinetobacter baumannii</i> from a worldwide survey

Kai Lucaßen, Carina Müller, Julia Wille et al. · Journal of Antimicrobial Chemotherapy · 2021 · 46 citations

Life Sciences, Infectious Diseases, Microbiology +17

Global update on the in vitro activity of tigecycline and comparators against isolates of Acinetobacter baumannii and rates of resistant phenotypes (2016–2018)

Harald Seifert, Joseph M. Blondeau, Kai Lucaßen et al. · Journal of Global Antimicrobial Resistance · 2022 · 45 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Diversity of amino acid substitutions in PmrCAB associated with colistin resistance in clinical isolates of Acinetobacter baumannii

Stefanie Gerson, Kai Lucaßen, Julia Wille et al. · International Journal of Antimicrobial Agents · 2019 · 44 citations · Full text

Life Sciences, Infectious Diseases, Microbiology +17

Comparison of the Acinetobacter baumannii Reference Strains ATCC 17978 and ATCC 19606 in Antimicrobial Resistance Mediated by the AdeABC Efflux Pump

Kai Lucaßen, Stefanie Gerson, Kyriaki Xanthopoulou et al. · Antimicrobial Agents and Chemotherapy · 2021 · 11 citations · Full text

Life Sciences, Microbiology, Molecular Biology +17